| Date Filed | Type | Description |
| 08/15/2023 |
4
| RIEDEL NORBERT G (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 3,075 shares
@ $0
Sold 1,241 shares
@ $138.1581, valued at
$171.5k
|
|
| 06/09/2023 |
4
| RIEDEL NORBERT G (Director) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.|
Txns:
| Granted 3,282 shares
@ $0
Granted 13,780 options to buy
@ $32.6, valued at
$449.2k
|
|
| 01/05/2023 |
4
| RIEDEL NORBERT G (EXECUTIVE CHAIRMAN OF THE BOD) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Granted 420,000 options to buy
@ $0.36, valued at
$151.2k
|
|
| 08/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2022 |
4
| RIEDEL NORBERT G (Director) has filed a Form 4 on Eton Pharmaceuticals, Inc.|
Txns:
| Granted 50,000 options to buy
@ $3.78, valued at
$189k
|
|
| 01/06/2022 |
4
| RIEDEL NORBERT G (Director) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.|
Txns:
| Exercised 14,270 restricted stock units
@ $0 |
|
| 12/08/2021 |
4
| RIEDEL NORBERT G (CEO) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Bought 100,000 shares
@ $2.23, valued at
$223k
|
|
| 12/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2021 |
4
| RIEDEL NORBERT G (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 2,246 shares
@ $0 |
|
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 05/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2021 |
4
| RIEDEL NORBERT G (CEO) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Granted 733,300 options to buy
@ $3.8, valued at
$2.8M
|
|
| 01/06/2021 |
4
| RIEDEL NORBERT G (Director) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.|
Txns:
| Exercised 14,270 restricted stock units
@ $0 |
|
| 10/30/2020 |
3
| RIEDEL NORBERT G (Director) has filed a Form 3 on Cerevel Therapeutics Holdings, Inc. |
| 08/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2020 |
4
| RIEDEL NORBERT G (CEO and President) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Granted 625,000 options to buy
@ $3.12, valued at
$2M
|
|
| 01/14/2020 |
4
| RIEDEL NORBERT G (CEO and President) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Bought 35,000 shares
@ $3, valued at
$105k
|
|
| 08/12/2019 |
4
| RIEDEL NORBERT G (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 1,920 shares
@ $0
Sold 726 shares
@ $135.6497, valued at
$98.5k
Granted 4,805 options to buy
@ $137.12, valued at
$658.9k
|
|
| 05/17/2019 |
4
| RIEDEL NORBERT G (CEO and President) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Granted 380,000 restricted stock units
@ $0 |
|
| 03/08/2019 |
4
| RIEDEL NORBERT G (Director) has filed a Form 4 on Eton Pharmaceuticals, Inc.|
Txns:
| Granted 12,500 options to buy
@ $7.31, valued at
$91.4k
|
|
| 01/07/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2018 |
4
| RIEDEL NORBERT G (Director) has filed a Form 4 on Eton Pharmaceuticals, Inc.|
Txns:
| Bought 5,000 shares
@ $6, valued at
$30k
|
|
| 11/14/2018 |
4
| RIEDEL NORBERT G (CEO and President) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Exercised 38,563 options to buy
@ $2.59, valued at
$99.9k
|
|
| 11/13/2018 |
3
| RIEDEL NORBERT G (Director) has filed a Form 3 on Eton Pharmaceuticals, Inc. |
| 09/21/2018 |
4
| RIEDEL NORBERT G (CEO and President) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Granted 427,265 options to buy
@ $27.43, valued at
$11.7M
|
|
| 08/13/2018 |
4
| RIEDEL NORBERT G (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 1,495 shares
@ $0
Sold 660 shares
@ $176.6107, valued at
$116.6k
Granted 3,735 options to buy
@ $177.73, valued at
$663.8k
|
|
| 06/26/2018 |
4
| RIEDEL NORBERT G (CEO and President) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Converted 37,790 shares
@ $0
Converted 48,367 shares
@ $0
Converted 30,324 shares
@ $0
Converted 2,718 shares
@ $0
Bought 2,400 shares
@ $16, valued at
$38.4k
Converted 1,042,482 convertible preferred
@ $0
Converted 75,000 convertible preferred
@ $0
Converted 1,334,254 convertible preferred
@ $0
Converted 836,541 convertible preferred
@ $0 |
|
| 06/20/2018 |
3
| RIEDEL NORBERT G (CEO and President) has filed a Form 3 on Aptinyx Inc. |
| 08/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|